Werewolf Therapeutics Ownership | Who Owns Werewolf Therapeutics?


OverviewForecastRevenueFinancialsChart

Werewolf Therapeutics Ownership Summary


Werewolf Therapeutics is owned by 12.54% institutional investors, 6.11% insiders, and 81.35% retail investors. Ra capital management is the largest institutional shareholder, holding 14.06% of HOWL shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.97% of its assets in Werewolf Therapeutics shares.

HOWL Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockWerewolf Therapeutics12.54%6.11%81.35%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Ra capital management6.14M14.06%$9.09M
Mpm asset management4.28M9.80%$6.34M
Pfm health sciences, lp2.91M6.65%$4.30M
Bioimpact capital2.39M5.46%$3.53M
Bank of america corp /de/2.15M5.16%$5.24M
Blackrock funding, inc. /de1.70M3.89%$2.52M
Blackrock1.59M3.82%$3.87M
Vanguard group1.42M3.25%$2.10M
Rubric capital management lp1.33M3.05%$1.97M
Geode capital management702.56K1.61%$1.04M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Dc funds, lp589.10K24.47%$871.87K
Mpm asset management4.28M5.10%$6.34M
Bioimpact capital2.39M0.50%$3.53M
Pfm health sciences, lp2.91M0.27%$4.30M
Sphera funds management626.81K0.17%$927.68K
Ra capital management6.14M0.12%$9.09M
Rubric capital management lp1.33M0.03%$1.97M
Levin capital strategies50.00K0.01%$74.00K
Bridgeway capital management109.59K0.00%$162.19K
Financial perspectives6.75K0.00%$9.99K

Top Buyers

HolderShares% AssetsChange
Blackrock1.59M0.00%1.42M
Bank of america corp /de/2.15M0.00%266.31K
Deutsche bank ag\101.63K0.00%83.17K
Blackrock funding, inc. /de1.70M0.00%63.38K
Levin capital strategies50.00K0.01%50.00K

Top Sellers

HolderShares% AssetsChange
Adage capital partners gp---2.00M
Monashee investment management---890.00K
Millennium management596.29K0.00%-727.48K
Eagle health investments lp---700.00K
Pfm health sciences, lp2.91M0.27%-493.28K

New Positions

HolderShares% AssetsChangeValue
Levin capital strategies50.00K0.01%50.00K$74.00K
Susquehanna group, llp33.86K-33.86K$50.12K
D. e. shaw17.78K-17.78K$26.31K
Intech investment management14.87K0.00%14.87K$22.00K
Two sigma securities12.74K0.00%12.74K$18.86K

Sold Out

HolderChange
Capital performance advisors llp-60.00
Russell investments group-86.00
Point72 (difc)-381.00
Macquarie group-940.00
Qube research-8.31K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202445-35.71%5,479,410-82.99%120.23%28-28.21%8-33.33%
Sep 30, 202469-4.17%31,964,492-0.84%731.22%38-15.56%12-7.69%
Jun 30, 20247214.29%32,236,039-0.05%771.00%4515.38%138.33%
Mar 31, 20246346.51%32,252,02716.56%881.46%3969.57%1271.43%
Dec 31, 20234322.86%27,669,99915.86%771.72%2376.92%775.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv883.18K1.97%82.90K
Vanguard US Total Market Shares ETF800.28K1.79%-
iShares Russell 2000 ETF690.08K1.54%-6.00K
HBM Healthcare Investments AG Ord396.80K0.91%-60.51K
Vanguard Institutional Extnd Mkt Idx Tr392.16K0.87%-
Fidelity Small Cap Index312.00K0.70%-5.84K
BIT Biotech Opportunities S241.06K0.54%-
iShares Russell 2000 Value ETF203.87K0.45%-
Fidelity Extended Market Index165.24K0.37%-1.05K
Vanguard Russell 2000 ETF139.78K0.31%3.29K

Recent Insider Transactions


DateNameRoleActivityValue
Jan 06, 2023RA CAPITAL MANAGEMENT, L.P.-Buy$4.10M
Dec 15, 2021Leonard Reid Chief Operating OfficerSell$1.89K
Dec 15, 2021Leonard Reid Chief Operating OfficerSell$38.36K
Jun 15, 2021RA CAPITAL MANAGEMENT, L.P. Buy$103.06K
Jun 16, 2021RA CAPITAL MANAGEMENT, L.P. Buy$124.14K

Insider Transactions Trends


DateBuySell
2025 Q1--
2024 Q2--
2024 Q1--
2023 Q2--
2023 Q11-

HOWL Ownership FAQ


Who Owns Werewolf Therapeutics?

Werewolf Therapeutics shareholders are primarily institutional investors at 12.54%, followed by 6.11% insiders and 81.35% retail investors. The average institutional ownership in Werewolf Therapeutics's industry, Biotech Stocks , is 68.48%, which Werewolf Therapeutics falls below.

Who owns the most shares of Werewolf Therapeutics?

Werewolf Therapeutics’s largest shareholders are Ra capital management (6.14M shares, 14.06%), Mpm asset management (4.28M shares, 9.80%), and Pfm health sciences, lp (2.91M shares, 6.65%). Together, they hold 30.51% of Werewolf Therapeutics’s total shares outstanding.

Does Blackrock own Werewolf Therapeutics?

Yes, BlackRock owns 3.82% of Werewolf Therapeutics, totaling 1.59M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 3.87M$. In the last quarter, BlackRock increased its holdings by 1.42M shares, a 863.47% change.

Who is Werewolf Therapeutics’s biggest shareholder by percentage of total assets invested?

Dc funds, lp is Werewolf Therapeutics’s biggest shareholder by percentage of total assets invested, with 24.47% of its assets in 589.1K Werewolf Therapeutics shares, valued at 871.87K$.

Who is the top mutual fund holder of Werewolf Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Werewolf Therapeutics shares, with 1.97% of its total shares outstanding invested in 883.18K Werewolf Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools